Literature DB >> 33457423

A Simple RFLP-Based Method for HFE Gene Multiplex Amplification and Determination of Hereditary Hemochromatosis-Causing Mutation C282Y and H63D Variant with Highly Sensitive Determination of Contamination.

Ludmilla Ogouma-Aworet1, Jean-Pierre Rabes1, Philippe de Mazancourt1,2.   

Abstract

Hereditary hemochromatosis is an autosomal recessive disorder with incomplete penetrance that results from excess iron absorption and can lead to chronic liver disease, fibrosis, cirrhosis, and hepatocellular carcinoma. The most common form of hereditary hemochromatosis in Western Europe is due to a homozygous mutation (p.(Cys282Tyr) or C282Y), in the HFE gene which encodes hereditary haemochromatosis protein. In the general European population, the frequency of the homozygous genotype is 0.4%, and this mutation explains up to 95% of hereditary hemochromatosis in France. We report here an improved PCR and restriction endonuclease assay based on multiplex amplification of HFE exon 4 (for C282Y detection), HFE exon 2 (for H63D detection), FZD1 gene (for digestion controls), and two Short Tandem Repeats (SE33 and FGA) for identity monitoring and contamination tracking. Fluorescent primers allow capillary electrophoresis, accurate allele tagging, and sensitive contamination detection.
Copyright © 2020 Ludmilla OGOUMA-AWORET et al.

Entities:  

Year:  2020        PMID: 33457423      PMCID: PMC7785358          DOI: 10.1155/2020/9396318

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  10 in total

1.  Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis.

Authors:  G P Jeffrey; S Chakrabarti; R A Hegele; P C Adams
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations.

Authors:  M K Stott; A P Fellowes; J D Upton; M J Burt; P M George
Journal:  Clin Chem       Date:  1999-03       Impact factor: 8.327

3.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

4.  Genetic screening for hemochromatosis: a cautionary tale.

Authors:  Jane Starczynski; Laura Hooper; Nageeb Ali; Mark Hill; Chris Fegan; Guy Pratt
Journal:  Clin Chem       Date:  2005-03       Impact factor: 8.327

5.  Presence of the hemochromatosis S65C mutation leads to failure of amplification in a multiplex C282Y/H63D PCR.

Authors:  Ankie Koeken; Ellen de Baar; Lianne Schrauwen; Christa Cobbaert
Journal:  Clin Chem       Date:  2007-09       Impact factor: 8.327

6.  IGD: a resource for intronless genes in the human genome.

Authors:  Amel Louhichi; Ahmed Fourati; Ahmed Rebaï
Journal:  Gene       Date:  2011-09-02       Impact factor: 3.688

7.  Sequence analysis and characterization of stutter products at the tetranucleotide repeat locus vWA.

Authors:  P S Walsh; N J Fildes; R Reynolds
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

Review 8.  HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.

Authors:  E H Hanson; G Imperatore; W Burke
Journal:  Am J Epidemiol       Date:  2001-08-01       Impact factor: 4.897

9.  HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors.

Authors:  N Arya; S Chakrabrati; R A Hegele; P C Adams
Journal:  Blood Cells Mol Dis       Date:  1999 Oct-Dec       Impact factor: 3.039

10.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.